Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO
| Autor: | Mainwaring, Paul N., Cunningham, David *, Gregory, Walter, Hoskin, Peter, Hancock, Barry, Norton, Andrew J., MacLennan, Ken, Smith, Paul, Hudson, Gillian Vaughan, Linch, David |
|---|---|
| Zdroj: | In Blood 15 May 2001 97(10):2991-2997 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|